Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis

BACKGROUND AND OBJECTIVES: Ocrelizumab improved clinical and MRI measures of disease activity and progression in three phase 3 multiple sclerosis (MS) studies. Post hoc analyses demonstrated a correlation between the ocrelizumab serum concentration and the degree of blood B-cell depletion, and body...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Stephen L., Bar-Or, Amit, Weber, Martin S., Kletzl, Heidemarie, Günther, Andreas, Manfrini, Marianna, Model, Fabian, Mercier, Francois, Petry, Claire, Wing, Qing, Koendgen, Harold, Smith, Terence, Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931184/
https://www.ncbi.nlm.nih.gov/pubmed/36792367
http://dx.doi.org/10.1212/NXI.0000000000200094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931184/
https://www.ncbi.nlm.nih.gov/pubmed/36792367
http://dx.doi.org/10.1212/NXI.0000000000200094

Ejemplares similares